Open access
87
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
Jesse D Ortendahl1 Health Economics, Partnership for Health, LLC, Beverly Hills, CA, USACorrespondence[email protected]
, Sonia J Pulgar2 Health Economics and Outcomes Research, Ipsen Biopharmaceuticals, Basking Ridge, NJ, USA
, Beloo Mirakhur3 Medical Affairs, Oncology, Ipsen Biopharmaceuticals, Basking Ridge, NJ, USA
, David Cox3 Medical Affairs, Oncology, Ipsen Biopharmaceuticals, Basking Ridge, NJ, USA
, Tanya GK Bentley1 Health Economics, Partnership for Health, LLC, Beverly Hills, CA, USA
& Alexandria T Phan4 GI Medical Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA
Pages 495-503
|
Published online: 16 Aug 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.